Investigational drug shows promise in increasing oxygen uptake for patients with heart condition

FHS
May 14, 2024
7:50 pm

People with a common heart condition were able to use significantly more oxygen while exercising after taking an investigational drug in an international clinical trial, according to a study published today in the New England Journal of Medicine.

Pharmalittle: Mid-year price hikes for U.S. drugs reaches new heights; onetime biotech CEO Vivek Ramaswamy sparks debate at GOP debate

Good morning, Pharmalittle readers. Reporter Andrew Joseph here filling in for Ed from STAT’s London outpost, where we’re feeling a bit of panic having just

August 24, 2023

Caltech spinout debuts with AI-driven ‘mirror peptide’ platform

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 22, 2024

Vitamin D-MS Link; Nootropic Gummies Laced With Psilocybin; Forecasting Seizures

Vitamin D levels before starting treatment were tied to subsequent multiple sclerosis (MS) disease activity. (Journal of Neurology, Neurosurgery, and Psychiatry) Several brands of nootropic

July 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.